ORGENTEC Diagnostika

Details: Published: 05 January 2021

Mainz, Germany – ORGENTEC offers efficient tools for routine quality control of Alegria^® assays in autoimmune disease diagnostics.

Details: Published: 17 March 2020

Mainz, Germany – As COVID-19 continues to impact the globe, ORGENTEC is positioned and prepared to make sure that we continue our business during this difficult period.

Details: Published: 14 November 2019

Mainz, Germany – ORGENTEC appoints John Garland Director International Sales.

Details: Published: 09 April 2019

Mainz, Germany – ORGENTEC Diagnostika, a leading specialty diagnostics company, announced today that its board of directors has appointed Gary Winer to president and chief executive officer, effective immediately. Mr. Winer will leverage his global healthcare leadership experience to further ORGENTEC’s long-term growth and position as one of the world’s premier providers of diagnostic assays specializing in autoimmune and infectious diseases

Details: Published: 18 September 2018

Mainz – Dr. Klaus Esperschidt is ready to join ORGENTEC as Vice President Operations.
Starting in Mid-September he will join the ORGENTEC company management and strengthen the operative activities of the company. He takes over the position from Dr. Michael Bartels, who will switch to the position of Vice President Commercials.

Details: Published: 28 June 2018

Mainz, Germany – Frederic W.P. Paquet has been appointed Director Sales International.

Details: Published: 19 February 2018

Mainz, Germany – University and Business Company – Meeting of two Worlds: Once again, students from Rhein Main University of Applied Sciences visited ORGENTEC Diagnostika to gain insights into the working world of a global medical technology company. Lectures, experiments and discussions were building bridges between everyday research, university and business – a successful initiative by biotechnology lecturer Prof. Ulrike Stadtmueller and the general management of ORGENTEC. The students learned about requirements and perspectives in the diagnostics industry and gained an impressive look behind the scenes of an international company.

Details: Published: 31 March 2017

Mainz, Germany – Effective April 1, 2017, Dr. Michael Bartels, VP Operations, will strengthen the executive management of ORGENTEC Diagnostika GmbH.

Details: Published: 04 October 2016

Mainz, Germany – We cordially welcome Dr. Michael Bartels who joins ORGENTEC Diagnostika in the role of Vice President Operations at the company’s headquarters in Mainz.

Details: Published: 08 June 2016

Mainz, Germany – ORGENTEC Diagnostika has a leading role in the prestigious research project EuroTEAM Arthritis (Towards Early diagnosis and biomarker validation in Arthritis Management), funded by the European Union with more than 5.7 million EUR for four years. Together with partners from 13 renowned European research institutions we present the progress of the project and our contribution to the discovery of novel biomarkers for rheumatoid arthritis at the EuroTEAM stand in the EULAR village from June 08-11.

Details: Published: 01 December 2015

New products and brand growth win over industry visitors

Details: Published: 18 June 2015

Merger of ORGENTEC Diagnostika and Corgenix Medical creates a global distribution network and offers more than 350 diagnostic assays

Mainz, Germany – The global diagnostics industry is welcoming ORGENTEC Diagnostika and Corgenix Medical Corporation to the 2015 American Association of Clinical Chemistry (AACC) Clinical Lab Expo in booth #3711. ORGENTEC completed its acquisition of Corgenix in March 2015 and is exhibiting for the first time at AACC. The combined specialty diagnostics company features a portfolio of more than 350 diagnostic tests, including ELISA, IFA, LFI, IT and immunoblot.

Details: Published: 03 June 2015

Corgenix Transfers to ORGENTEC Exclusive Worldwide Distribution Rights. Effective July 1st.

Details: Published: 06 May 2015

1000th laboratory device ships to Argentina as a regional art edition

Details: Published: 19 March 2015

US Affiliate Expands Specialty Diagnostics Company’s Global Presence and Test Menu

Details: Published: 14 November 2014

Mainz / Düsseldorf - At the world’s biggest trade show for medical technology MEDICA commencing on 12^th of November, ORGENTEC joins over 4500 other international exhibitors displaying latest projects and innovations. Therefore, we may give you an update on ORGENTEC’s most recent product developments!

Details: Published: 14 November 2014

Mainz / Düsseldorf - At the world’s biggest trade show for medical technology MEDICA commencing on 12^th of November, ORGENTEC joins over 4500 other international exhibitors displaying latest projects and innovations. Therefore, we may give you an update on ORGENTEC’s most recent product developments!

Details: Published: 01 September 2014

ORGENTEC acquires Corgenix

Corgenix Enters into Agreement to be Acquired by ORGENTEC Diagnostika

Corgenix shareholders to receive $0.27 in cash per share
Transaction valued at approximately $16 million
Following the transaction, Corgenix will remain headquartered in Broomfield, Colo., as a subsidiary of Orgentec Diagnostika
Strategic Acquisition Creates Leading Global Specialty Diagnostics Company

Details: Published: 30 June 2014

Employer’s Day at ORGENTEC Diagnostika – Students get a Taste of the Laboratory at the Mainz Company Headquarters

Mainz - Students from the RheinMain University of Applied Sciences crossed the Rhine for a glimpse of the working world in a Medical Technology company with global reach.
In presentations and discussions with the visitors from the Ruesselsheim campus, a bridge was constructed between the reality of research, the university, and scientific thinking – a successful initiative driven by Biotechnology Professor Dr. Ulrike Stadtmüller and the directors of ORGENTEC.

Details: Published: 14 May 2014

Water Street Invests in Orgentec Diagnostika

Health Care Firm Partners with European Specialty Diagnostics Company; Former Beckman Coulter Chairman & CEO to Serve as Chairman

ORGENTEC Diagnostika | news and press releases

Sebia acquires ORGENTEC Diagnostika

Alegria^® Check: For quality asurance in the lab

How ORGENTEC is handling the COVID-19 challenge

Driving commercial success